← Back to Search

Behavioral Intervention

Experimental Condition for HIV/AIDS (PrEPDSA Trial)

N/A
Waitlist Available
Led By LaRon E Nelson, PhD
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up self-reported prep initiation at 30-days and prep adherence at 60-days post enrollment.
Awards & highlights

PrEPDSA Trial Summary

Aim 1: Adapt Ottawa Decision Support Framework for the HIV PrEP decisional needs of African, Caribbean and Black (ACB) Canadian patients Aim 2. Pilot Test The Adapted Decision-Support Intervention Using a Two-Arm Randomized Controlled Design

Eligible Conditions
  • HIV/AIDS

PrEPDSA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~self-reported prep initiation at 30-days and prep adherence at 60-days post enrollment.
This trial's timeline: 3 weeks for screening, Varies for treatment, and self-reported prep initiation at 30-days and prep adherence at 60-days post enrollment. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in baseline (initiation of PrEP) to adherence of PrEP for ACB Canadians

PrEPDSA Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental ConditionExperimental Treatment1 Intervention
Patients assigned to the experimental condition (LDQ + DS and HDQ + DS) will be asked to use the bookmarked link to the decision-aid within the first 7-14 days (and thereafter as needed) during the study period. The routine care group will be asked to use a bookmarked link to frequently asked questions on tenofovir + emtricitabine for PrEP. All groups will be compared on decision-quality at 14-days, self-reported PrEP initiation at 30-days, and PrEP adherence at 60-days post enrollment.

Find a Location

Who is running the clinical trial?

Unity Health TorontoLead Sponsor
537 Previous Clinical Trials
447,449 Total Patients Enrolled
LaRon E Nelson, PhDPrincipal InvestigatorUnity Health Toronto

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Decision Support Intervention Adapted for HIV Pre-Exposure Prophylaxis for Adoption and Adherence for Black Canadians
2019. "Decision Support Intervention Adapted for HIV Pre-Exposure Prophylaxis for Adoption and Adherence for Black Canadians". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03637244.
~15 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top